Wave Studies

Skip to Content

Advancing Care for Long QT Syndrome.

One Wave at a Time.

Now Enrolling: Wave II Clinical Study for LQT2 and LQT3!

© 2026 Thryv Therapeutics, Inc. All rights reserved.

Follow our journey

Wave II has active study sites now enrolling across the United States including:

📍 Mayo Clinic — Rochester, MN
📍 Mass General Hospital — Boston, MA
📍 UCSF — San Francisco, CA
📍 Univ Illinois, Chicago — Chicago, IL

Wave II has a new enrollment site — and it's now open. 📍 HonorHealth Research Institute — Scottsdale, AZ is now accepting participants for Wave II, a Phase 2/3 clinical trial for adults with Long QT Syndrome Type 2 (LQT2). Led by Dr. Ank

Many people ask: "What's involved if I join Wave II?" Fair question. Here's the answer — slide by slide. The commitment is real, but so is the support. Every step involves a dedicated study coordinator, and no decision is required unt

We know considering a clinical study comes with questions. Our study team is here to help. 💚

Visit wavestudies.com/wave-2 to learn more.

Sharing some photos from our team’s time in Chicago at the Heart Rhythm Society Annual Meeting (April 23–26), one of the largest yearly gatherings of heart rhythm specialists in the world. ❤️

We loved spending time with the team at the @

Research is underway for LQTS.
If you or someone you know has been diagnosed with LQTS Type 2, the Wave II study is enrolling. Learn more at wavestudies.com/wave-2.

Participation is voluntary.
The Wave II study is sponsored by Thryv Therapeutics In

LQTS can be present even without symptoms.
That’s why awareness, genetic testing, and family screening matter.

#LongQTSyndrome #GeneticTesting #HeartHealth #RareDiseaseAwareness #PatientEducation

Knowing the facts can help support earlier recognition and care.

#LongQTSyndrome #HeartHealth #RareDisease #AwarenessMatters #PatientEducation

© Thryv Therapeutics Inc. All rights reserved.